(Q42711742)

5 November 2017

title

Role of haem oxygenase in the renoprotective effects of soluble epoxide hydrolase inhibition in diabetic spontaneously hypertensive rats (English)

1 reference

Soluble epoxide hydrolase

5 November 2017

main subject

0 references

author

Krishna Rao Maddipati

object named as

Krishna Rao Maddipati

6

0 references

author name string

Ahmed A Elmarakby

1

1 reference

5 November 2017

Jessica Faulkner

2

1 reference

5 November 2017

Chelsey Pye

3

1 reference

5 November 2017

Katelyn Rouch

4

1 reference

5 November 2017

Abdulmohsin Alhashim

5

1 reference

5 November 2017

Babak Baban

7

1 reference

5 November 2017

language of work or name

English

0 references

publication date

1 October 2013

1 reference

5 November 2017

1 reference

5 November 2017

volume

125

1 reference

5 November 2017

issue

7

1 reference

5 November 2017

page(s)

349-359

1 reference

Pathogenic perspectives for the role of inflammation in diabetic nephropathy.

5 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Prediction, progression and prevention of diabetic nephropathy. The Minkowski Lecture 2005.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Is There a Role for Mammalian Target of Rapamycin Inhibition in Renal Failure due to Mesangioproliferative Nephrotic Syndrome?

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Cardiovascular disease in recent onset diabetes mellitus

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Reno-protective mechanisms of epoxyeicosatrienoic acids in cardiovascular disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Endothelin A receptor blockade reduces diabetic renal injury via an anti-inflammatory mechanism

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Induction of hemeoxygenase-1 reduces glomerular injury and apoptosis in diabetic spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Soluble epoxide hydrolase as a therapeutic target for cardiovascular diseases

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Deletion of soluble epoxide hydrolase gene improves renal endothelial function and reduces renal inflammation and injury in streptozotocin-induced type 1 diabetes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Upregulation of heme oxygenase-1 combined with increased adiponectin lowers blood pressure in diabetic spontaneously hypertensive rats through a reduction in endothelial cell dysfunction, apoptosis and oxidative stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

PPARalpha agonist fenofibrate protects the kidney from hypertensive injury in spontaneously hypertensive rats via inhibition of oxidative stress and MAPK activity

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Induction of hemeoxygenase-1 attenuates the hypertension and renal inflammation in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

An orally active epoxide hydrolase inhibitor lowers blood pressure and provides renal protection in salt-sensitive hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Inhibition of soluble epoxide hydrolase improves the impaired pressure-natriuresis relationship and attenuates the development of hypertension and hypertension-associated end-organ damage in Cyp1a1-Ren-2 transgenic rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Soluble epoxide hydrolase gene deletion attenuates renal injury and inflammation with DOCA-salt hypertension

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Genetic disruption of soluble epoxide hydrolase is protective against streptozotocin-induced diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Inhibition or deletion of soluble epoxide hydrolase prevents hyperglycemia, promotes insulin secretion, and reduces islet apoptosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Soluble epoxide hydrolase deficiency alters pancreatic islet size and improves glucose homeostasis in a model of insulin resistance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Pharmacological inhibition of soluble epoxide hydrolase ameliorates diet-induced metabolic syndrome in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Differential renal gene expression in prehypertensive and hypertensive spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Increases in plasma trans-EETs and blood pressure reduction in spontaneously hypertensive rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Soluble epoxide hydrolase in the generation and maintenance of high blood pressure in spontaneously hypertensive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Administration of a substituted adamantyl urea inhibitor of soluble epoxide hydrolase protects the kidney from damage in hypertensive Goto-Kakizaki rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Epoxyeicosatrienoic acid agonist rescues the metabolic syndrome phenotype of HO-2-null mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

EET agonist prevents adiposity and vascular dysfunction in rats fed a high fat diet via a decrease in Bach 1 and an increase in HO-1 levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Heme oxygenase isoform-specific expression and distribution in the rat kidney

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Treatment of obese diabetic mice with a heme oxygenase inducer reduces visceral and subcutaneous adiposity, increases adiponectin levels, and improves insulin sensitivity and glucose tolerance

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Induction of renoprotective gene expression by cobalt ameliorates ischemic injury of the kidney in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Redox regulation of HIF-1alpha levels and HO-1 expression in renal medullary interstitial cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Hypoxic preconditioning and tolerance via hypoxia inducible factor (HIF) 1alpha-linked induction of P450 2C11 epoxygenase in astrocytes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Epoxyeicosatrienoic acids and/or their metabolites promote hypoxic response of cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Novel soluble epoxide hydrolase inhibitor protects mitochondrial function following stress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Early nephropathy in type 1 diabetes: a new perspective on who will and who will not progress

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Detection of renal function decline in patients with diabetes and normal or elevated GFR by serial measurements of serum cystatin C concentration: results of a 4-year follow-up study

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Endothelin receptor A-specific stimulation of glomerular inflammation and injury in a streptozotocin-induced rat model of diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Distinct actions of endothelin A-selective versus combined endothelin A/B receptor antagonists in early diabetic kidney disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Glomerular 20-HETE, EETs, and TGF-beta1 in diabetic nephropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Transforming growth factor-beta, 20-HETE interaction, and glomerular injury in Dahl salt-sensitive rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Regulation of transforming growth factor beta in diabetic nephropathy: implications for treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Thrombospondin-1 is an endogenous activator of TGF-beta in experimental diabetic nephropathy in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

Uncoupling of proliferation and cytokines from suppression within the CD4+CD25+Foxp3+ T-cell compartment in the 1st year of human type 1 diabetes

21 January 2018

1 reference

https://api.crossref.org/works/10.1042%2FCS20130003

21 January 2018

Identifiers

DOI

10.1042/CS20130003

1 reference

5 November 2017

1 reference